Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) (100207MS-H)
This study has been completed.
Sponsor:
University of Turku
Collaborator:
Bayer
Information provided by (Responsible Party):
Merja Soilu-Hänninen, University of Turku
ClinicalTrials.gov Identifier:
NCT01432704
First received: August 16, 2011
Last updated: September 12, 2011
Last verified: September 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |